Shahneen Sandhu - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Shahneen Sandhu

This paper is made freely available by the publisher.

2024 Joaquin Mateo

ORCID

, Johann S. de Bono

ORCID

ORCID

ORCID

ORCID

, Shahneen Sandhu

ORCID

ORCID

, Neeraj Agarwal

ORCID

ORCID

, Antoine Thiery-Vuillemin, Mustafa Özgüroğlu

ORCID

ORCID

, Nobuaki Matsubara, Jae Young Joung

ORCID

, Charles Padua and 8 other authors

Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Adriana Hepner

ORCID

, Judith M. Versluis, Roslyn Wallace, Clara Allayous

ORCID

, Lauren Julia Brown

ORCID

, Claudia Trojaniello, Camille Lea Gerard

ORCID

, Yanina Jl Jansen, Prachi Bhave

ORCID

ORCID

, Andrew Haydon

ORCID

, Olivier Michielin, Joanna Mangana, Oliver Klein

ORCID

, Alexander N. Shoushtari and 13 other authors

The features and management of acquired resistance to PD1-based therapy in metastatic melanoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, Marie Bretagne, John R. Power, Javid J. Moslehi, Paul Gougis, Damien Amelin, Agnes Dechartres, Lorenz H. Lehmann, Pierre-Yves Courand, Jennifer Cautela, Joachim Alexandre, Adrien Procureur, Antoine Rozes and 87 other authors

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023)

Upload

This paper is made freely available by the publisher.

2023 Anna Galligan

ORCID

, Roslyn Wallace, Balasubramanian Krishnamurthy, Thomas W. H. Kay, Nirupa Sachithanandan

ORCID

, Cherie Chiang

ORCID

, Shahneen Sandhu

ORCID

, Rodney J. Hicks, Amir Iravani

ORCID

Increased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis

Download from doi.org

This paper is made freely available by the publisher.

Anna Galligan, Amir Iravani, Arian Lasocki, Roslyn Wallace, Alison M. Weppler, Nirupa Sachithanandan, Cherie Chiang, Peter G. Colman, John Wentworth, Lavinia Spain, George Au-Yeung, Belinda Lee, Thomas W. H. Kay, Rodney J. Hicks, Shahneen Sandhu

ORCID

and 1 other authors

Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

M. Saad, K. N. Chi, S. K. Sandhu

ORCID

, G. Attard, D. Ye, L. Li, W. Jung, S.-T. Pang, P. S. J. Francis, S. Li, S. Dibaj, J. Zhang, W. Kim, A. Lopez-Gitlitz, D. Wu and 4 other authors

258MO Niraparib plus abiraterone acetate plus prednisone (NIRA+AAP) as first-line treatment in patients with BRCA+ metastatic castration-resistant prostate cancer (mCRPC): Second interim analysis in the Asian subgroup of the MAGNITUDE study

Upload

This paper is made freely available by the publisher.

Domenico Mallardo, Rachel Woodford, Alexander M. Menzies, Lisa Zimmer, Andrew Williamson, Egle Ramelyte, Florentia Dimitriou, Alexandre Wicky, Roslyn Wallace, Mario Mallardo, Alessio Cortellini, Alfredo Budillon, Victoria Atkinson, Shahneen Sandhu

ORCID

, Michielin Olivier and 6 other authors

The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab

Download from doi.org

This paper is made freely available by the publisher.

Adi Diab

ORCID

ORCID

, Shahneen Sandhu

ORCID

, Georgina V. Long

ORCID

, Paolo A. Ascierto

ORCID

ORCID

ORCID

, Fabio Franke, Tudor E. Ciuleanu, Caio Pereira, Eva Muñoz Couselo

ORCID

, Fernanda Bronzon Damian

ORCID

, Michael Schenker

ORCID

, Aldo Perfetti, Celeste Lebbe

ORCID

and 11 other authors

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results

Download from doi.org

This paper is made freely available by the publisher.

Ymke van der Pol, Norbert Moldovan, Jip Ramaker, Sanne Bootsma, Kristiaan J. Lenos, Louis Vermeulen, Shahneen Sandhu

ORCID

, Idris Bahce, D. Michiel Pegtel, Stephen Q. Wong, Sarah-Jane Dawson

ORCID

, Dineika Chandrananda

ORCID

, Florent Mouliere

ORCID

The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

K. N. N. Chi, E. Castro, G. Attard, M. R. Smith, S. K. Sandhu

ORCID

, E. Efstathiou, G. Roubaud, E. J. J. Small, A. J. P. D. S. Gomes, D. Rathkopf, M. Saad, H. P. Gurney, W. Jung, G. E. Mason, S. Dibaj and 5 other authors

LBA85 Niraparib (NIRA) with abiraterone acetate plus prednisone (AAP) as first-line (1L) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: Three-year update and final analysis (FA) of MAGNITUDE

Upload

This paper was not found in any repository, but could be made available legally by the author.

D. Goode, S. Keerthikumar, S. Gupta, A. M. Joshua, L. Emmett, M. Crumbaker, T. Singer, E. Lam, L. Fernandez, E. Jimenez, D. Zhang, Y. Lin, R. J. Wenstrup, A. Pasam, R. Hicks and 3 other authors

1825P Molecular features of circulating tumour cells (CTCs) associate with response to 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)

Upload

This paper was not found in any repository, but could be made available legally by the author.

G. Attard, S. K. Sandhu

ORCID

, D. Rathkopf, E. Castro, M. Saad, M. R. Smith, E. J. J. Small, D. Olmos, A. J. P. D. S. Gomes, G. Roubaud, B. Zurawski, E. Efstathiou, D. Wu, B. Diorio, K. Urtishak and 5 other authors

1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

L. Emmett, S. Subramaniam, M. Crumbaker, A. M. Joshua, A. J. Weickhardt, S. T. Lee, S. Ng, R. J. Francis, J. C. H. Goh, D. A. Pattison, H. Tan, I. D. Kirkwood, S. K. Sandhu

ORCID

, A. Nguyen, C. Gedye and 5 other authors

LBA84 Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC): A randomised, phase II trial: ENZA-p (ANZUP 1901)

Upload

This paper was not found in any repository, but could be made available legally by the author.

L. G. Horvath, I. D. Davis, A. Martin, R. Zielinski, A. Thomson, T. H. Tan, S. K. Sandhu

ORCID

, M. N. Reaume, D. Pook, F. Parnis, S. North, G. M. Marx, J. A. McCaffrey, R. S. McDermott, N. Lawrence and 5 other authors

1792P Effects of enzalutamide on overall survival +/- early docetaxel in participants aged less than 70 yrs versus greater than or equal to 70 yrs in ENZAMET (ANZUP 1304)

Upload

This paper was not found in any repository, but could be made available legally by the author.

J. S. de Bono, S. K. Sandhu

ORCID

, K. Fizazi, J. Sun, A. Ward, E. S. Antonarakis

1842TiP Phase II randomized trial of two dose levels of vobramitamab duocarmazine in participants with metastatic castration resistant prostate cancer (mCRPC; TAMARACK)

Upload

This paper was not found in any repository, but could be made available legally by the author.

S. K. Sandhu

ORCID

, G. Gotto, F. E. Vera-Badillo, S.-S. Byun, H. J. Cutuli, A. J. P. D. S. Gomes, C. Helissey, L. I. Karsh, A. Peer, D. D. Preto

ORCID

, Y.-S. Pu, R. Ravilla, G. Roubaud, I. A. Skoneczna, W. Kim and 5 other authors

1835P A prospective study to determine the prevalence of DNA repair defects in patients (pts) with advanced prostate cancer (PC)

Upload

This paper was not found in any repository, but could be made available legally by the author.

Julia Lai-Kwon, Andrisha-Jade Inderjeeth, Karolina Lisy, Shahneen Sandhu

ORCID

, Claudia Rutherford, Michael Jefford

Corrigendum to ‘Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review [European Journal of Cancer 184 (2023) 83–105]

Upload

This paper was not found in any repository, but could be made available legally by the author.

Oliver John Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini

ORCID

, Stefan Suciu, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu

ORCID

, James Larkin and 15 other authors

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

Rebecca Lee

ORCID

, Mario Mandala

ORCID

, Georgina V. Long, Alexander M. M. Eggermont, Alexander C. J. van Akkooi, Shahneen Sandhu

ORCID

, Claus Garbe, Paul Lorigan

ORCID

Adjuvant therapy for stage II melanoma: the need for further studies

Upload

This paper was not found in any repository, but could be made available legally by the author.

Thaidy Moreno, Meng Zhang, Arian Lundberg, Raunak Shrestha, Martin Sjöström, Anu Pasam, Adam Foye, Anna Trigos, Felix Feng, Shahneen Sandhu

ORCID

, David A. Quigley

Abstract PR003: Convergent evolution in DNA repair-deficient mCRPC in response to targeted therapy

Upload

Missing publications? Search for publications with a matching author name.